Biomerica, Inc. BMRA
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.05% | 24.09% | 13.94% | 28.19% | 40.68% |
| Total Depreciation and Amortization | -1.73% | 5.25% | 5.34% | 5.15% | 6.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.02% | -83.90% | -1.84% | -31.87% | -18.95% |
| Change in Net Operating Assets | 995.83% | -155.21% | 142.02% | 126.74% | -209.09% |
| Cash from Operations | -42.99% | 10.96% | 24.93% | 40.44% | 45.02% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.30% | 97.30% | 48.65% | 91.84% | -68.18% |
| Cash from Investing | 97.30% | 97.30% | 68.85% | 94.52% | 28.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.19% | -13.20% | -30.75% | 716.07% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 68.18% | 14.89% | 70.97% | 30.11% | 18.52% |
| Cash from Financing | 20.26% | 10.56% | -28.35% | 947.83% | 3,841.98% |
| Foreign Exchange rate Adjustments | -280.00% | 0.00% | 190.91% | 200.00% | 225.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -237.34% | 38.40% | 23.84% | 103.59% | 104.51% |